Quest Diagnostics rises after quarterly profit beat
Shares of lab operator Quest Diagnostics DGX.N rise 6.7% to $172.67 premarket
DGX posts Q1 adj. profit of $2.21 per share helped by robust demand for its diagnostic tests, beating analysts' estimates of $2.15, according to data compiled by LSEG
Company reports Q1 revenue of $2.65 billion vs estimates of $2.63 billion
Company continues to expect annual adj. profit in the range of $9.55 and $9.80 per share vs estimates of $9.68
DGX maintains its annual net revenue forecast in the range of $10.70 billion to $10.85 billion vs estimates of $10.78 billion
As of last close, DGX had risen 7.3% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Intel Foundry Gains ‘High-Profile’ Customer, Tesla Becomes First Major Customer for 14A Technology

Robinhood Stock Predictions: Can HOOD Reach the $1,000 Milestone?

Anthropic Eclipses OpenAI in Secondary Market as Valuation Hits $1 Trillion Milestone, Is the AI Market Overheating Now?

Tesla Officially Announces. Third-Generation Humanoid Robot to Debut Mid-Year, Mass Production to Start in Third Quarter

Intel Better-Than-Expected Earnings Released, Stock Surges 20% After-Hours, AI Computing Power Enters CPU Moment?

Tradingkey








